KHIRON LIFE SCIENCES CORP (KHRN.CA) Fundamental Analysis & Valuation

TSX-V:KHRN • CA49374L3065

0.04 CAD
0 (0%)
Last: May 5, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This KHRN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, KHRN scores 2 out of 10 in our fundamental rating. KHRN was compared to 34 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of KHRN have multiple concerns. KHRN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. KHRN.CA Profitability Analysis

1.1 Basic Checks

  • KHRN had negative earnings in the past year.
  • KHRN had a negative operating cash flow in the past year.
KHRN.CA Yearly Net Income VS EBIT VS OCF VS FCFKHRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -10M -20M -30M

1.2 Ratios

  • The profitability ratios for KHRN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KHRN.CA Yearly ROA, ROE, ROICKHRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -100 -200 -300 -400

1.3 Margins

  • The Gross Margin of KHRN (19.51%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of KHRN has declined.
  • The Profit Margin and Operating Margin are not available for KHRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.81%
GM growth 5YN/A
KHRN.CA Yearly Profit, Operating, Gross MarginsKHRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. KHRN.CA Health Analysis

2.1 Basic Checks

  • KHRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, KHRN has more shares outstanding
  • The debt/assets ratio for KHRN is higher compared to a year ago.
KHRN.CA Yearly Shares OutstandingKHRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M
KHRN.CA Yearly Total Debt VS Total AssetsKHRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -5.28, we must say that KHRN is in the distress zone and has some risk of bankruptcy.
  • KHRN has a Altman-Z score of -5.28. This is in the lower half of the industry: KHRN underperforms 70.45% of its industry peers.
  • A Debt/Equity ratio of 0.05 indicates that KHRN is not too dependend on debt financing.
  • KHRN's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. KHRN outperforms 68.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -5.28
ROIC/WACCN/A
WACC6.71%
KHRN.CA Yearly LT Debt VS Equity VS FCFKHRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.91 indicates that KHRN should not have too much problems paying its short term obligations.
  • KHRN has a Current ratio (1.91) which is comparable to the rest of the industry.
  • KHRN has a Quick Ratio of 1.91. This is a bad value and indicates that KHRN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • KHRN's Quick ratio of 0.91 is in line compared to the rest of the industry. KHRN outperforms 43.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 0.91
KHRN.CA Yearly Current Assets VS Current LiabilitesKHRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. KHRN.CA Growth Analysis

3.1 Past

  • KHRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.04%.
  • Looking at the last year, KHRN shows a very strong growth in Revenue. The Revenue has grown by 38.20%.
  • KHRN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 143.00% yearly.
EPS 1Y (TTM)-59.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.56%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y143%
Revenue growth 5YN/A
Sales Q2Q%-3.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
  • KHRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.15% yearly.
EPS Next Y39.13%
EPS Next 2Y31.88%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year36.43%
Revenue Next 2Y38.09%
Revenue Next 3Y45.7%
Revenue Next 5Y40.15%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
KHRN.CA Yearly Revenue VS EstimatesKHRN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
KHRN.CA Yearly EPS VS EstimatesKHRN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

1

4. KHRN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • KHRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year KHRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KHRN.CA Price Earnings VS Forward Price EarningsKHRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KHRN.CA Per share dataKHRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

  • KHRN's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y25.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KHRN.CA Dividend Analysis

5.1 Amount

  • No dividends for KHRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

KHRN.CA Fundamentals: All Metrics, Ratios and Statistics

KHIRON LIFE SCIENCES CORP

TSX-V:KHRN (5/5/2023, 7:00:00 PM)

0.04

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.47%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.19M
Revenue(TTM)16.14M
Net Income(TTM)-30.66M
Analysts45.71
Price Target0.1 (150%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.99%
Min EPS beat(2)0.99%
Max EPS beat(2)0.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-23.31%
Min Revenue beat(2)-30.18%
Max Revenue beat(2)-16.44%
Revenue beat(4)1
Avg Revenue beat(4)-33.87%
Min Revenue beat(4)-93.32%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.09
BVpS0.15
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.51%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.81%
GM growth 5YN/A
F-Score2
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 143.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 0.91
Altman-Z -5.28
F-Score2
WACC6.71%
ROIC/WACCN/A
Cap/Depr(3y)345.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.56%
EPS Next Y39.13%
EPS Next 2Y31.88%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)38.2%
Revenue growth 3Y143%
Revenue growth 5YN/A
Sales Q2Q%-3.82%
Revenue Next Year36.43%
Revenue Next 2Y38.09%
Revenue Next 3Y45.7%
Revenue Next 5Y40.15%
EBIT growth 1Y14.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.73%
EBIT Next 3Y30.54%
EBIT Next 5YN/A
FCF growth 1Y43.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.83%
OCF growth 3YN/A
OCF growth 5YN/A

KHIRON LIFE SCIENCES CORP / KHRN.CA FAQ

What is the ChartMill fundamental rating of KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to KHRN.CA.


Can you provide the valuation status for KHIRON LIFE SCIENCES CORP?

ChartMill assigns a valuation rating of 3 / 10 to KHIRON LIFE SCIENCES CORP (KHRN.CA). This can be considered as Overvalued.


Can you provide the profitability details for KHIRON LIFE SCIENCES CORP?

KHIRON LIFE SCIENCES CORP (KHRN.CA) has a profitability rating of 0 / 10.


What is the financial health of KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?

The financial health rating of KHIRON LIFE SCIENCES CORP (KHRN.CA) is 1 / 10.


What is the expected EPS growth for KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?

The Earnings per Share (EPS) of KHIRON LIFE SCIENCES CORP (KHRN.CA) is expected to grow by 39.13% in the next year.